CG
ASMB icon

Cutler Group’s Assembly Biosciences ASMB Stock Holding History

Cutler Group’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-483
Closed -$32K – 4344
2020
Q1 		$32K Buy
+483
New +$104K ﹤0.01% 1998
2019
Q1 		– Sell
-667
Closed -$82K – 3995
2018
Q4 		$82K Buy
+667
New +$193K 0.01% 1155
2018
Q3 		– Sell
-108
Closed -$13K – 4062
2018
Q2 		$13K Buy
108
+83
+332% +$43.9K ﹤0.01% 2470
2018
Q1 		$1K Buy
+25
New +$15.5K ﹤0.01% 3962
2017
Q4 		– Sell
-208
Closed -$1K – 4852
2017
Q3 		$1K Sell
208
-209
-50% -$64K ﹤0.01% 5325
2017
Q2 		$28K Buy
+417
New +$117K ﹤0.01% 3064

Other funds holding ASMB

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Cutler Group's ASMB Position: Q3 2022 in Review

Cutler Group sold out of Assembly Biosciences (ASMB) in Q3 2022, closing a stake of 17 shares.

Cutler Group first reported a position in ASMB in Q3 2017 and held it in 17 quarters. The position peaked at $171K in Q4 2018. 50 funds tracked by Wall St. Rank hold ASMB as of Q3 2022.

  • Cutler Group reported no remaining Assembly Biosciences position as of Q3 2022 after selling out during the quarter.
  • Cutler Group sold 17 Assembly Biosciences shares in Q3 2022.
  • Cutler Group first reported a position in Assembly Biosciences in Q3 2017 and held it in 17 quarters.
  • Cutler Group's Assembly Biosciences position peaked at $171K in Q4 2018.
  • 50 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2022.

Based on Cutler Group's 13F filing for Q3 2022, filed 25 Oct 2022.